Details
Manufacturer
GENZYME CORPORATION(UNITED STATES)
Registraction Number
MAL20091972ACZ
Content:
- Active Ingredient: Idursulfase
- Excipients: Various inactive ingredients to stabilize the solution
- Mucopolysaccharidosis Type II (Hunter Syndrome): Used to treat the non-neurological symptoms of MPS II in patients with the iduronate-2-sulfatase (I2S) enzyme deficiency.
- Dosage and Administration: The dosage and administration should be determined by a healthcare provider based on the patient's weight and medical condition. It is typically administered via intravenous infusion.
- Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze.
- Handling: Use aseptic techniques to avoid contamination. Dispose of syringes and needles safely after use.
- Monitoring: Regular monitoring of the patient's condition and any potential side effects as advised by the healthcare provider.
View more about ELAPRASE SOLUTION FOR INTRAVENOUS INFUSION on main site